… [9] An important feature of initial studies of erlotinib efficacy was that while the overall … from
patients demonstrating sensitivity to erlotinib and gefitinib, with nucleotide sequencing of their …

… In the present study, we utilized … erlotinib. The CE7Ns could distinguish NSCLC subtype
PC-9 cells (EGFR E746-A750 deletion, erlotinib-sensitive) from A549 (EGFR wild-type, erlotinib-…

… , erlotinib, or afatinib) can be used (when available) until further data from comparative studies
are … but not by the FDA; erlotinib and afatinib are approved by both agencies. Gefitinib and …

… with gefitinib or erlotinib from January 2001 to March 2005 were included in this study. Those
… The patients included in this study represent all of the patients from our institution who met …

… for erlotinib reports a drug interaction between erlotinib and PPIs or H2RAs.The solubility of
erlotinib is … Comparative study with ranitidine and cimetidine on gastric secretion in normal …

… , the treatment benefits of erlotinib, docetaxel, and … comparative value in the US healthcare
setting is unclear. The objective of this study was to evaluate the cost-effectiveness of erlotinib …

… However, recently, two important studies have suggested that EGFR expression evaluated
by immunohistochemistry can be associated with gefitinib [15] and erlotinib [16] sensitivity. On …

… Therefore, our study could not include any … , our study is the first comparative analysis for
T790 M mutation rates as a resistance mechanism between afatinib and gefitinib or erlotinib. …

… 25 Blaszkowsky LS, Kulke KH and Ryan DP: A phase II study of erlotinib in combination with
… Moore MJ, Goldstein D and Hamm J: Erlotinib plus gemcitabine compared to gemcitabine …

… study was to prepare and evaluate erlotinib loaded chitosan nanoparticles for their anticancer
potential. Also, to study the … Erlotinib loaded chitosan nanoparticles were prepared by ionic …